🇺🇸 Rifaximin plus lactulose in United States

Rifaximin plus lactulose (Rifaximin plus lactulose) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Rifaximin plus lactulose in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Rifaximin plus lactulose approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Rifaximin plus lactulose in United States?

Institute of Liver and Biliary Sciences, India is the originator. The local marketing authorisation holder may differ — check the official source linked above.